Many people are simply unaware of the existence of the FIT test or underestimate its importance in colorectal cancer ...

Aug. 14, 2024 — A new study has identified diet-derived molecules called metabolites as main drivers of young-onset colorectal cancer risk, especially those associated with red and processed meat.

The research, published online ahead of print in the British Journal of Health Psychology, found that in people who ...

As a colorectal cancer surgeon, I can tell you the answer is, yes — plenty. In fact, it's thought that more than half of cases in the UK are preventable. So what can you do to stop the disease ...

Overall colon cancer rates in the United States have declined steadily over the last 30 years. But rates of colon cancer in young adults have risen dramatically during this period for unknown reasons.

Colorectal cancer, also known as bowel cancer, is a cancer formed by uncontrolled cell growth in the colon or rectum (parts of the large intestine), or in the appendix. Genetic analysis shows that ...

Colon cancer, which affects the large intestine, is one of the most common cancers in the United States. Medical experts typically group it with rectal cancer in a category called colorectal cancer.

A recent study by the American Cancer Society (ACS) provides jarring insights into the connection between diet and cancer. While dietary risk factors might statistically appear to play a minor ...

The most common form of colorectal cancer, microsatellite-stable colorectal cancer (MSS CRC), can currently only be treated to a limited extent with modern immunotherapies. A research team led by ...

By Roni Caryn Rabin Adults under age 50 have been developing breast cancer and colorectal cancer at increasingly higher rates over the last few decades, and alcohol use may be one factor driving ...

A new treatment for locally advanced rectal cancer shows favourable results in that surgery can sometimes be avoided completely. It also reduces the risk of recurrence. The method has been ...

Researchers investigated the efficacy of total neoadjuvant treatment followed by nonoperative management in patients with locally advanced rectal cancer.